PHOTOSJenna Bush Hager & Hoda Kotb Weigh Themselves Live On 'Today' & Are Shocked By The Results!
Jenna Bush Hager and Hoda Kotb are putting dieting to the test. On the Monday, November 18 episode, Jenna, 37, and Hoda, 55, of Today with Hoda and Jenna, stepped onto a scale in front of millions of viewers to kick start their experiment with intermittent fasting.
Hoda introduced the segment by expressing that the two had been stressing over the unique dieting concept, however, it wouldn’t stop them from weighing themselves. “Okay, I haven’t done this in a long time,” Jenna said before stepping onto the scale. “It’ll be fine.”
The two held hands and told each other not to look down, but not before they removed their shoes in order to get a more accurate reading. “It’s like jumping off a cliff,” Jenna said jokingly before finally standing on the scale after some hesitation.
The two even switched scales to ensure one wasn’t inaccurate. For Hoda, the scale read 158lbs., and for Jenna, who recently had her third child in August 2019, the scale read, 171lbs.
Want OK! each day? Sign up here!
“This is why I don’t really weigh myself,” Jenna said. The talk show host was shocked to see that her numbers were more than the weight that was logged on her Fitbit. “Y’all know what is plugged into my Fitbit for real?” the talk show host asked. “130 pounds. I weigh 40 more pounds than I tell everybody I do! I think I weigh twice as much as my sister,” Jenna teasingly added. “Like, two Barbaras could fit in me.”
Hoda and Jenna explained that they weren’t heavily focused on losing weight. “We’re doing it to be healthy,” Jenna said, to which Hoda added, “And to also improve our brain health and everything else.” Intermittent fasting has become a growing trend among celebrities.
After the weigh-in, Hoda and Jenna sat down with Dr. Natalie Azar to learn more about how to successfully fast.
Dr. Natalie explained that intermittent fasting could help those who were obese or had Type 2 diabetes, which could have negative effects on your health in the long-run. “I think more in its infancy is the stuff about longevity and Alzheimer’s, and, you know, maybe it has a role in treating or managing chronic disease and cancer,” Dr. Natalie explained. “There are no large trials of any of those things, but mechanistically it’s a very interesting, hot topic right now.”
